Siemens Healthineers yabonye uruhushya rwo gukoresha FDA byihutirwa byo gupima antibody ya SARS-CoV-2

New York-Icyumweru gishize, Ubuyobozi bushinzwe ibiryo n'ibiyobyabwenge bwahaye Siemens Healthineers uruhushya rwo gukoresha byihutirwa kubushakashatsi bwarwo Advia Centaur SARS-CoV-2 IgG cyangwa sCOVG.
Immunoassay ya Chemiluminescence yagenewe kumenya neza na kimwe cya kabiri cyo kumenya immunoglobuline G cyangwa IgG kurwanya SARS-CoV-2 muri serumu na plasma.Ikizamini gikorerwa kuri Siemens 'Advia Centaur XP, Advia Centaur XPT na sisitemu ya immunoassay ya Advia Centaur CP.
Nk’uko FDA ibivuga, iki kizamini gishobora gukoreshwa na laboratoire yemewe na CLIA kugirango ikore ibizamini biciriritse cyangwa bikomeye.
Muri Werurwe uyu mwaka, immunoassay ya SARS-CoV-2 IgG iyobowe na Siemens AG, ifite icyicaro i Erlangen mu Budage, ku isesengura ryayo rya Atellica IM, yakiriye EUA na FDA.
Politiki Yibanga.Amategeko n'amabwiriza.Copyright © 2021 GenomeWeb, ishami ryubucuruzi ryitumanaho rya Crain.uburenganzira bwose burabitswe.